# Pelago

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pelago-2

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.pelagohealth.com
- Total disclosed funding: $114M
- Latest round: Series C (Mar 28, 2024)
- Investors on record: 18

## About

Founded in 2017 by co-founders Maroof Ahmed, Sarim Siddiqui, and Yusuf Sherwani and based in California, US, Digital Therapeutics, Inc., doing business as Pelago, is an online platform that provides therapeutic techniques to help individuals quit addictions such as tobacco, vaping, alcohol, and opioids. In March 2024, Pelago raised USD 50.50 million in Series C funding led by investor Atomico, with participation from investors Eight Roads and GreyMatter, Kinnevik, Octopus Ventures, and Y Combinator. The Series C funding values Pelago at USD 315.51 million post-money.
 
The company offers physicians, nurses, counsellors, and coaches, ensuring comprehensive care that addresses both physical and mental health needs. The company offers digital CBT tools that help users manage cravings and develop healthier coping mechanisms. Pelago provides a hub for medication management, allowing members to receive prescriptions and integrate their care with pharmacy partners. Devices such as breathalyzers and urinary test kits help track progress and outcomes, offering members motivation and accountability.
 
 The company will use the funding to increase its market presence and verify the return on investment

## Funding rounds

- Series C, Mar 28, 2024, $51M — Eight Roads Ventures, Atomico, Kinnevik, Y Combinator, Octopus Investments, GreyMatter
- Series B, Jul 19, 2021, $49M — Atomico, Kinnevik, TriplePoint Capital, StartUp Health, Octopus Investments
- Series A, Jan 30, 2020, $12M — Semper Ventures, TriplePoint Capital, Y Combinator, StartUp Health, Octopus Investments, Village Global, Serena Ventures
- Seed, May 22, 2018, $1.1M — AAF Management, Village Global, Pioneer Fund
- Seed, Feb 12, 2018, $0.9M — Telefonica, Merck Global Health Innovation Fund, Y Combinator, Force Over Mass Capital
- Seed, Sep 1, 2017 — Merck & Co. Inc. Master Retirement Trust, Wayra, Force Over Mass Capital

## Investors

- Merck & Co. Inc. Master Retirement Trust — Seed
- Wayra (https://capitalatlas.ai/funds/wayra) — Seed
- Force Over Mass Capital (https://capitalatlas.ai/funds/force-over-mass-capital) — Seed
- Telefonica (https://capitalatlas.ai/funds/telefonica) — Seed
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed, Series A, Series C
- AAF Management (https://capitalatlas.ai/funds/aaf-management) — Seed
- Village Global (https://capitalatlas.ai/funds/village-global) — Seed, Series A
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Semper Ventures (https://capitalatlas.ai/funds/semper-ventures) — Series A
- TriplePoint Capital (https://capitalatlas.ai/funds/triplepoint-capital) — Series A, Series B
- StartUp Health (https://capitalatlas.ai/funds/startup-health) — Series A, Series B
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A, Series B, Series C
- Serena Ventures — Series A
- Atomico (https://capitalatlas.ai/funds/atomico) — Series B, Series C
- Kinnevik (https://capitalatlas.ai/funds/kinnevik) — Series B, Series C
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series C
- GreyMatter (https://capitalatlas.ai/funds/greymatter) — Series C